cfSNV: a software tool for the sensitive detection of somatic mutations from cell-free DNA

Shuo Li, Ran Hu, Colin Small, Ting-Yu Kang, Chun-Chi Liu, Xianghong Jasmine Zhou, Wenyuan Li

Published: 2023-02-26 DOI: 10.1038/s41596-023-00807-w

somatic mutations

cfDNA

cfSNV

mutation detection

whole-exome sequencing

AI 解读

Author Correction: Efficient and strand-specific profiling of replicating chromatin with enrichment and sequencing of protein-associated nascent DNA in mammalian cells

Practical and concise synthesis of nucleoside analogs

Preparation and quantitative analysis of multicenter luminescence materials for sensing function

Inferring cellular and molecular processes in single-cell data with non-negative matrix factorization using Python, R and GenePattern Notebook implementations of CoGAPS

GLORI for absolute quantification of transcriptome-wide m6A at single-base resolution

Generating human bone marrow organoids for disease modeling and drug discovery

Responsive and activable nanomedicines for remodeling the tumor microenvironment

PepSeq: a fully in vitro platform for highly multiplexed serology using customizable DNA-barcoded peptide libraries

Optimizing the Cell Painting assay for image-based profiling

Ligand functionalization of titanium nanopattern enables the analysis of cell–ligand interactions by super-resolution microscopy

查看全部

Sections

Figures

References

Cell-free DNA (cfDNA) in blood, viewed as a surrogate for tumor biopsy, has many clinical applications, including diagnosing cancer, guiding cancer treatment and monitoring treatment response. All these applications depend on an indispensable, yet underde
Introduction
Materials
Procedure
Troubleshooting
Timing
Anticipated results
- References
- References
References
ACKNOWLEDGMENTS

Kothen-Hill, S. T. et al. Deep learning mutation prediction enables early stage lung cancer detection in liquid biopsy. Available at https://openreview.net/forum?id=H1DkN7ZCZ (2018).
Zviran, A. et al. Genome-wide cell-free DNA mutational integration enables ultra-sensitive cancer monitoring. Nat. Med. 26, 1114–1124 (2020).
Koboldt, D. C. Best practices for variant calling in clinical sequencing. Genome Med. 12, 1–13 (2020).
Chen, Z. et al. Systematic comparison of somatic variant calling performance among different sequencing depth and mutation frequency. Sci. Rep. 10, 3501 (2020).
VanderLaan, P. A. et al. Success and failure rates of tumor genotyping techniques in routine pathological samples with non-small-cell lung cancer. Lung Cancer 84, 39–44 (2014).
Murtaza, M. et al. Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer. Nat. Commun. 6, 8760 (2015).
Phallen, J. et al. Direct detection of early-stage cancers using circulating tumor DNA. Sci. Transl. Med. 9, eaan2415 (2017).
Newman, A. M. et al. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage. Nat. Med. 20, 548–554 (2014).
Ueda, M. et al. Somatic mutations in plasma cell-free DNA are diagnostic markers for esophageal squamous cell carcinoma recurrence. Oncotarget 7, 62280–62291 (2016).
Adalsteinsson, V. A. et al. Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors. Nat. Commun. 8, 1324 (2017).
Camus, V. et al. Digital PCR for quantification of recurrent and potentially actionable somatic mutations in circulating free DNA from patients with diffuse large B-cell lymphoma. Leuk. Lymphoma 57, 2171–2179 (2016).
Rothwell, D. G. et al. Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study. Nat. Med. 25, 738–743 (2019).
Li, S. et al. Sensitive detection of tumor mutations from blood and its application to immunotherapy prognosis. Nat. Commun. 12, 1–14 (2021).
Goldberg, S. B. et al. Early assessment of lung cancer immunotherapy response via circulating tumor DNA. Clin. Cancer Res. 24, 1872–1880 (2018).
Iwama, E. et al. Monitoring of somatic mutations in circulating cell-free DNA by digital PCR and next-generation sequencing during afatinib treatment in patients with lung adenocarcinoma positive for EGFR activating mutations. Ann. Oncol. 28, 136–141 (2017).
Fontanilles, M. et al. Non-invasive detection of somatic mutations using next-generation sequencing in primary central nervous system lymphoma. Oncotarget 8, 48157–48168 (2017).
Chaudhuri, A. A. et al. Early detection of molecular residual disease in localized lung cancer by circulating tumor DNA profiling. Cancer Discov. 7, 1394–1403 (2017).
Li, S. et al. cfTrack, a method of exome-wide mutation analysis of cell-free DNA to simultaneously monitor the full spectrum of cancer treatment outcomes including MRD, recurrence, and evolution. Clin. Cancer Res. 28, 1841–1853 (2022).
Choudhury, A. D. et al. Tumor fraction in cell-free DNA as a biomarker in prostate cancer. JCI Insight 3, e122109 (2018).
Li, S. et al. cfSNV: a software tool for the sensitive detection of somatic mutations from cell-free DNA. Jasminezhoulab/cfSNV_docker: cfSNV docker image. Available at https://github.com/jasminezhoulab/cfSNV_docker (2022).
Jiang, P. et al. Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients. Proc. Natl Acad. Sci. USA 112, E1317–E1325 (2015).
Jiang, P. et al. Preferred end coordinates and somatic variants as signatures of circulating tumor DNA associated with hepatocellular carcinoma. Proc. Natl Acad. Sci. USA 115, E10925–E10933 (2018).
Abbosh, C. et al. Phylogenetic ctDNA analysis depicts early-stage lung cancer evolution. Nature 545, 446–461 (2017).
Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213–219 (2013).
Van der Auwera, G. A. et al. From FastQ data to high‐confidence variant calls: the genome analysis toolkit best practices pipeline. Curr. Protoc. Bioinforma. 43, 11.10.1–11.10.33 (2013).
DePristo, M. A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43, 491–498 (2011).
Pellini, B. & Chaudhuri, A. A. Circulating tumor DNA minimal residual disease detection of non–small-cell lung cancer treated with curative intent. J. Clin. Oncol. 40, 567–575 (2022).
Roth, A. et al. JointSNVMix: a probabilistic model for accurate detection of somatic mutations in normal/tumour paired next-generation sequencing data. Bioinformatics 28, 907–913 (2012).
Kim, S. et al. Strelka2: fast and accurate calling of germline and somatic variants. Nat. Methods 15, 591–594 (2018).
Xu, C. et al. A review of somatic single nucleotide variant calling algorithms for next-generation sequencing data. Comput. Struct. Biotechnol. J. 16, 15–24 (2018).
Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows–Wheeler transform. Bioinformatics 25, 1754–1760 (2009).
Broad Institute. Picard tools. Available at https://broadinstitute.github.io/picard/ (2019).
Li, H. et al. The sequence alignment/map format and SAMtools. Bioinformatics 25, 2078–2079 (2009).
Mose, L. E. et al. ABRA: improved coding indel detection via assembly-based realignment. Bioinformatics 30, 2813–2815 (2014).
Opasic, L. et al. How many samples are needed to infer truly clonal mutations from heterogenous tumours? BMC Cancer 19, 1–11 (2019).
Butler, T. M. et al. Exome sequencing of cell-free DNA from metastatic cancer patients identifies clinically actionable mutations distinct from primary disease. PloS One 10, e0136407 (2015).
Kurtz, D. M. et al. Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA. Nat. Biotechnol. 39, 1537–1547 (2021).
Liebs, S. et al. Liquid biopsy assessment of synchronous malignancies: a case report and review of the literature. ESMO Open 4, e000528 (2019).
Ramesh, N. et al. Decoding the evolutionary response to prostate cancer therapy by plasma genome sequencing. Genome Biol. 21, 1–22 (2020).
Magoč, T. & Salzberg, S. L. FLASH: fast length adjustment of short reads to improve genome assemblies. Bioinformatics 27, 2957–2963 (2011).
Merkel, D. Docker: lightweight linux containers for consistent development and deployment. Linux J. 2014, 2 (2014).
Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841–842 (2010).
Arnold, K., Gosling, J. & Holmes, D. The Java Programming Language (Addison Wesley Professional, 2005).
Van Rossum, G. & Drake, F. L. Python 3 Reference Manual (CreateSpace, Scotts Valley, CA, 2009).
Harris, C. R. et al. Array programming with NumPy. Nature 585, 357–362 (2020).
McKinney, W. Data structures for statistical computing in python. In Proceedings of the 9th Python in Science Conference, Vol. 445 (SCIPY, 2010).
Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res. 12, 2825–2830 (2011).
Virtanen, P. et al. SciPy 1.0: fundamental algorithms for scientific computing in Python. Nat. Methods 17, 261–272 (2020).
R Core Team. R: a language and environment for statistical computing. Available at https://www.R-project.org/ (2018).
Eddelbuettel, D. & Romain, F. Rcpp: seamless R and C++ integration. J. Stat. Softw. 40, 1–18 (2011).
Sherry, S. T., Ward, M. & Sirotkin, K. dbSNP—database for single nucleotide polymorphisms and other classes of minor genetic variation. Genome Res. 9, 677–679 (1999).
Lander, E. S. et al. Initial sequencing and analysis of the human genome. Nature 409, 860–921 (2001).

cfSNV: a software tool for the sensitive detection of somatic mutations from cell-free DNA

推荐阅读